Next Article in Journal
Synthetic Genetic Targeting of Genome Instability in Cancer
Next Article in Special Issue
Influence of Levamisole and Other Angiogenesis Inhibitors on Angiogenesis and Endothelial Cell Morphology in Vitro
Previous Article in Journal
Genomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin’s Lymphoma
Previous Article in Special Issue
Emerging Roles of ADAMTSs in Angiogenesis and Cancer
Cancers 2013, 5(2), 726-738; doi:10.3390/cancers5020726

Effects of Ellagic Acid on Angiogenic Factors in Prostate Cancer Cells

, 1
, 1
, 1
, 1
, 2
, 3
 and 1,*
Received: 3 May 2013 / Revised: 31 May 2013 / Accepted: 7 June 2013 / Published: 19 June 2013
(This article belongs to the Special Issue Tumour Angiogenesis)
View Full-Text   |   Download PDF [741 KB, uploaded 19 June 2013]   |   Browse Figures
Abstract: Background: Several natural antioxidants, including ellagic acid (EA), have been reported to have chemotherapeutic activity in vivo and in vitro settings. Cytochrome P450 (CYP) activity and synthesis of both epoxyeicosatrienoic acids (EETs) and 20-hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE), together with vascular endothelial growth factor (VEGF) and heme oxygenase system (HO) have emerged as important modulators of tumor growth and metastasis. Methods: The anti-angiogenic effects of EA were investigated in the human prostatic cancer cell line LnCap. HO-1, HO-2, CYP2J2 and soluble epoxyde hydrolase (sEH) expressions were evaluated by western blotting. Levels of VEGF and osteoprotegerin (OPG) were determined in the culture supernatant using an ELISA assay, while CYP mRNAs were determined by qRT-PCR. Results: EA treatment induced a significant decrease (p < 0.05) in HO-1, HO-2 and CYP2J2 expression, and in VEGF and OPG levels. Similarly CYP2J2, CYP4F2 and CYPA22 mRNAs were significantly (p < 0.05) down-regulated by EA treatment. The decrease in CYP2J2 mRNA was associated with an increase in sEH expression. Conclusions: Results reported in the present study highlighted the ability of EA to modulate a new pathway, in addition to anti-proliferative and pro-differentiation properties, via a mechanism that involves a decrease in eicosanoid synthesis and a down-regulation of the HO system in prostate cancer.
Keywords: prostate cancer; angiogenesis; heme-oxygenase; cytochrome P450 prostate cancer; angiogenesis; heme-oxygenase; cytochrome P450
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Vanella, L.; Di Giacomo, C.; Acquaviva, R.; Barbagallo, I.; Li Volti, G.; Cardile, V.; Abraham, N.G.; Sorrenti, V. Effects of Ellagic Acid on Angiogenic Factors in Prostate Cancer Cells. Cancers 2013, 5, 726-738.

AMA Style

Vanella L, Di Giacomo C, Acquaviva R, Barbagallo I, Li Volti G, Cardile V, Abraham NG, Sorrenti V. Effects of Ellagic Acid on Angiogenic Factors in Prostate Cancer Cells. Cancers. 2013; 5(2):726-738.

Chicago/Turabian Style

Vanella, Luca; Di Giacomo, Claudia; Acquaviva, Rosaria; Barbagallo, Ignazio; Li Volti, Giovanni; Cardile, Venera; Abraham, Nader G.; Sorrenti, Valeria. 2013. "Effects of Ellagic Acid on Angiogenic Factors in Prostate Cancer Cells." Cancers 5, no. 2: 726-738.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert